Composition for treatment and management of addiction and method of preparation thereof are disclosed herein. The disclosed herbal composition includes herb and mineral which facilitate in treating addiction. It may be used to treat addiction such as alcohol addiction, tobacco addiction, excessive smoking, drugs abuse etc. Further, the disclosed composition may also be instrumental in treating complications associated with addiction and withdrawal symptoms.

The present invention relates to a process for preparing pharmaceutical compositions and other herbal products derived from herbs of Traditional Chinese Medicine (TCM), including Radix astragali (MilkvetchHuang Qi), Ligusticum chuanxiong (Chuan Xiong), Radix angelicae sinensis (Chinese AngelicaDang Gui) and Radix polygalae (Thinleaf milkwortYuan Zhi). The process includes a single extraction of the TCM herbs by heating in a hydro-alcoholic solvent, wherein the alcohol may be ethanol. FIG. 2 provides an overview of one embodiment of the process. The invention also relates to products of the process of the invention, and their use in the treatment of stroke and various neurological disorders.

The present invention relates to a process for preparing pharmaceutical compositions and other herbal products derived from herbs of Traditional Chinese Medicine (TCM), including Radix astragali (MilkvetchHuang Qi), Ligusticum chuanxiong (Chuan Xiong), Radix angelicae sinensis (Chinese AngelicaDang Gui) and Radix polygalae (Thinleaf milkwortYuan Zhi). The process includes a single extraction of the TCM herbs by heating in a hydro-alcoholic solvent, wherein the alcohol may be ethanol. FIG. 2 provides an overview of one embodiment of the process. The invention also relates to products of the process of the invention, and their use in the treatment of stroke and various neurological disorders.

The present invention relates to a process for preparing pharmaceutical compositions and other herbal products derived from herbs of Traditional Chinese Medicine (TCM), including Radix astragali (MilkvetchHuang Qi), Ligusticum chuanxiong (Chuan Xiong), Radix angelicae sinensis (Chinese AngelicaDang Gui) and Radix polygalae (Thinleaf milkwortYuan Zhi). The process includes a single extraction of the TCM herbs by heating in a hydro-alcoholic solvent, wherein the alcohol may be ethanol. FIG. 2 provides an overview of one embodiment of the process. The invention also relates to products of the process of the invention, and their use in the treatment of stroke and various neurological disorders.

A plant-based, non-nicotine therapy for physiologically decreasing or eliminating the desire to use nicotine in humans by means of extracted Acorus gramineus is described. In particular, methods, pharmaceutical compositions, and kits for treating nicotine addiction by way of Acorus gramineus extracts are described. According to one example, Acorus gramineus rhizome water extracts are administered in an oral formulation containing 0.1 to 99% (w/w) water extract to a subject suffering from nicotine addiction.

A plant-based, non-nicotine therapy for physiologically decreasing or eliminating the desire to use nicotine in humans by means of extracted Acorus gramineus is described. In particular, methods, pharmaceutical compositions, and kits for treating nicotine addiction by way of Acorus gramineus extracts are described. According to one example, Acorus gramineus rhizome water extracts are administered in an oral formulation containing 0.1 to 99% (w/w) water extract to a subject suffering from nicotine addiction.

A plant-based, non-nicotine therapy for physiologically decreasing or eliminating the desire to use nicotine in humans by means of extracted Acorus gramineus is described. In particular, methods, pharmaceutical compositions, and kits for treating nicotine addiction by way of Acorus gramineus extracts are described. According to one example, Acorus gramineus rhizome water extracts are administered in an oral formulation containing 0.1 to 99% (w/w) water extract to a subject suffering from nicotine addiction.

A 7H-azulene [1,2,3-i,j] isoquinolin-7-one compound, a single crystal and a use thereof are provided. The compound has a structure as shown in a formula (I). The present invention obtains a crude extract of Acorus calamus L., then extracts with different polar solvents in sequence and separates column chromatography to obtain a novel alkaloid compound, which is expected to be developed into a novel class of drug exerting neuroprotective effects, so as to prevent and treat senile dementia, stroke and epilepsy diseases.

##STR00001##

There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.

There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.